“Right now, the throughput for cell and gene therapies is limited. We don’t fully understand how to manufacture therapies in a reproducible manner, from scaling up and scaling out. This type of facility will hopefully …

“This is a complete game-changer for New Jersey. BioCentriq is a state-of-the-art facility that will attract cutting-edge companies and innovation from around the world.”

NJII has made significant progress in the area of regenerative medicine and we are very excited about their new center and the opportunity for companies of varying sizes to leverage the center for cell and …